Orris

Seminar on nural tude defect

Reading File
Finding Sources
Finding Sources
Searching PubMed

"neural tube defects"[MeSH Terms] AND prevention

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Searching Images

myelomeningocele neural tube defect spina bifida

This clinical photograph captures an intraoperative view of a fetal surgical repair for a myelomeningocele (spina bifida). The image displays a large 5 x 5 cm neural tube defect located in the lumbosacral region, characterized by exposed neural placode and surrounding meningeal tissue. Associated with the defect is a visible kyphotic spinal deformity. Surgical instruments are seen manipulating the area where the repair is being performed. The procedure demonstrates the closure technique using a skin patch sewn over the open defect to protect the spinal cord and prevent further damage from amniotic fluid exposure. The surgical field includes medical drapes, sutures, and specialized instrumentation utilized in maternal-fetal surgery. This visual illustrates key concepts in pediatric neurosurgery and fetal intervention, specifically the management of congenital central nervous system malformations and the techniques required for anatomical closure of myelomeningocele.

This clinical photograph captures an intraoperative view of a fetal surgical repair for a myelomeningocele (spina bifida). The image displays a large 5 x 5 cm neural tube defect located in the lumbosacral region, characterized by exposed neural placode and surrounding meningeal tissue. Associated with the defect is a visible kyphotic spinal deformity. Surgical instruments are seen manipulating the area where the repair is being performed. The procedure demonstrates the closure technique using a skin patch sewn over the open defect to protect the spinal cord and prevent further damage from amniotic fluid exposure. The surgical field includes medical drapes, sutures, and specialized instrumentation utilized in maternal-fetal surgery. This visual illustrates key concepts in pediatric neurosurgery and fetal intervention, specifically the management of congenital central nervous system malformations and the techniques required for anatomical closure of myelomeningocele.

This clinical photograph shows a posterior view of a human fetus presenting with an open neural tube defect (NTD), specifically spina bifida aperta (myelomeningocele). The primary abnormality is located in the mid-to-lower thoracic spine, indicated by a black arrow. The defect appears as a large, midline ulcerated lesion where the skin and underlying vertebral arches have failed to fuse, exposing the neural placode and underlying meningeal tissues. The lesion shows evidence of hemorrhage and irregular borders. Surrounding the spinal defect, the skin appears thinned and tense. Additionally, the lower extremities and overall body structure are visible; there is evidence of skin maceration or epidermal desquamation on the right thigh, which may be secondary to intrauterine positioning or underlying pathology. This image illustrates a severe congenital central nervous system malformation, serving as a primary example of spinal dysraphism for medical education in embryology, neonatology, and fetal pathology.

This clinical photograph shows a posterior view of a human fetus presenting with an open neural tube defect (NTD), specifically spina bifida aperta (myelomeningocele). The primary abnormality is located in the mid-to-lower thoracic spine, indicated by a black arrow. The defect appears as a large, midline ulcerated lesion where the skin and underlying vertebral arches have failed to fuse, exposing the neural placode and underlying meningeal tissues. The lesion shows evidence of hemorrhage and irregular borders. Surrounding the spinal defect, the skin appears thinned and tense. Additionally, the lower extremities and overall body structure are visible; there is evidence of skin maceration or epidermal desquamation on the right thigh, which may be secondary to intrauterine positioning or underlying pathology. This image illustrates a severe congenital central nervous system malformation, serving as a primary example of spinal dysraphism for medical education in embryology, neonatology, and fetal pathology.

This composite educational image illustrates Neural Tube Defects (NTDs) and related genetic expression data. Panels (A) and (B) are clinical photographs of newborns showing manifestations of spina bifida. Image A demonstrates a cystic spina bifida (myelomeningocele or meningocele) presented as a prominent, spherical, fluid-filled sac protruding from the lumbosacral region, covered by thin, translucent skin with pink and purplish discoloration. Image B shows a different case with a less pronounced protrusion, possibly indicating spina bifida occulta or a smaller closed neural tube defect with associated skin dimpling or scarring. Panels (C) and (D) are quantitative bar charts related to DNMT1 gene expression. Chart C compares ΔCt values between control mothers (CTM) and case mothers (CM), showing higher ΔCt (lower expression) in mothers who gave birth to NTD babies. Chart D shows the fold change (2−ΔΔCt) comparing case mothers to their respective fetuses (CF), illustrating a significant reduction in DNMT1 expression in the affected newborns. This material is designed for medical genetics and pediatrics, demonstrating the phenotypic presentation of NTDs alongside molecular epigenetic findings.

This composite educational image illustrates Neural Tube Defects (NTDs) and related genetic expression data. Panels (A) and (B) are clinical photographs of newborns showing manifestations of spina bifida. Image A demonstrates a cystic spina bifida (myelomeningocele or meningocele) presented as a prominent, spherical, fluid-filled sac protruding from the lumbosacral region, covered by thin, translucent skin with pink and purplish discoloration. Image B shows a different case with a less pronounced protrusion, possibly indicating spina bifida occulta or a smaller closed neural tube defect with associated skin dimpling or scarring. Panels (C) and (D) are quantitative bar charts related to DNMT1 gene expression. Chart C compares ΔCt values between control mothers (CTM) and case mothers (CM), showing higher ΔCt (lower expression) in mothers who gave birth to NTD babies. Chart D shows the fold change (2−ΔΔCt) comparing case mothers to their respective fetuses (CF), illustrating a significant reduction in DNMT1 expression in the affected newborns. This material is designed for medical genetics and pediatrics, demonstrating the phenotypic presentation of NTDs alongside molecular epigenetic findings.

This clinical photograph shows a neonate in a prone position, demonstrating a prominent neural tube defect in the lumbar spine. The lesion is consistent with spina bifida cystica (myelomeningocele). There is a visible midline protrusion with an open, erythematous neural plaque (placode) where the spinal cord and meningeal tissues are exposed through a defect in the skin and vertebral arches. The surrounding skin appears thin at the margins of the sac. The lower extremities are visible, appearing somewhat flaccid with internal rotation of the thighs, which is clinically significant for potential neurological impairment associated with the spinal lesion. The image is a primary resource for medical education regarding congenital central nervous system malformations and neonatal physical examination findings.

This clinical photograph shows a neonate in a prone position, demonstrating a prominent neural tube defect in the lumbar spine. The lesion is consistent with spina bifida cystica (myelomeningocele). There is a visible midline protrusion with an open, erythematous neural plaque (placode) where the spinal cord and meningeal tissues are exposed through a defect in the skin and vertebral arches. The surrounding skin appears thin at the margins of the sac. The lower extremities are visible, appearing somewhat flaccid with internal rotation of the thighs, which is clinically significant for potential neurological impairment associated with the spinal lesion. The image is a primary resource for medical education regarding congenital central nervous system malformations and neonatal physical examination findings.

Searching Images

anencephaly encephalocele neural tube defect

This composite diagnostic image features three grayscale fetal ultrasound panels (A, B, and C) illustrating different types of neural tube defects (NTDs) in the second trimester. Panel A shows anencephaly, characterized by the absence of the cranial vault and cerebral hemispheres; the protruding orbits and residual neural tissue create the classic 'Mickey Mouse' sign in a coronal or transverse view. Panel B demonstrates an encephalocele, specifically an occipital myelomeningocele, visualized as a fluid-filled, sac-like protrusion through a defect in the occipital bone. Panel C displays a longitudinal view of the fetal spine with a thoracolumbar myelomeningocele (highlighted by a blue circle). This view reveals a disruption in the spinal line with a cystic mass protruding from the posterior aspect of the vertebrae, indicative of spina bifida aperta where the spinal cord and meninges are exposed. The collection serves as an educational reference for prenatal screening and the sonographic identification of major congenital central nervous system malformations.

This composite diagnostic image features three grayscale fetal ultrasound panels (A, B, and C) illustrating different types of neural tube defects (NTDs) in the second trimester. Panel A shows anencephaly, characterized by the absence of the cranial vault and cerebral hemispheres; the protruding orbits and residual neural tissue create the classic 'Mickey Mouse' sign in a coronal or transverse view. Panel B demonstrates an encephalocele, specifically an occipital myelomeningocele, visualized as a fluid-filled, sac-like protrusion through a defect in the occipital bone. Panel C displays a longitudinal view of the fetal spine with a thoracolumbar myelomeningocele (highlighted by a blue circle). This view reveals a disruption in the spinal line with a cystic mass protruding from the posterior aspect of the vertebrae, indicative of spina bifida aperta where the spinal cord and meninges are exposed. The collection serves as an educational reference for prenatal screening and the sonographic identification of major congenital central nervous system malformations.

This clinical photograph shows a human fetal specimen demonstrating anencephaly, a severe open neural tube defect. The image highlights a significant malformation of the cephalic region characterized by the absence of a major portion of the brain (forebrain and cerebral hemispheres) and the overlying cranial vault (acrania). An arrow points to the area of the defect where disorganized neural tissue, often referred to as the area cerebrovasculosa, is exposed. In contrast to the severe cranial deformity, the rest of the fetal anatomy, including the torso, upper limbs, and lower limbs with visible feet, appears relatively well-developed and intact. A ruler is positioned to the left for scale, and surgical forceps are visible on the right, indicating a pathological or embryological examination. This specimen serves as a classic educational example of a failure of the neural tube to close at the cranial end during early embryonic development.

This clinical photograph shows a human fetal specimen demonstrating anencephaly, a severe open neural tube defect. The image highlights a significant malformation of the cephalic region characterized by the absence of a major portion of the brain (forebrain and cerebral hemispheres) and the overlying cranial vault (acrania). An arrow points to the area of the defect where disorganized neural tissue, often referred to as the area cerebrovasculosa, is exposed. In contrast to the severe cranial deformity, the rest of the fetal anatomy, including the torso, upper limbs, and lower limbs with visible feet, appears relatively well-developed and intact. A ruler is positioned to the left for scale, and surgical forceps are visible on the right, indicating a pathological or embryological examination. This specimen serves as a classic educational example of a failure of the neural tube to close at the cranial end during early embryonic development.

A clinical photograph of a fetus in posterior view, demonstrating a large occipital encephalocele. The primary pathology is a significant, sac-like protrusion in the occipital region of the head, indicated by a black arrow. This mass is smooth, taut, and spherical, representing the herniation of intracranial contents through a midline skull defect. The fetus exhibits thin, translucent skin with visible underlying vascular patterns, characteristic of early second-trimester development. The limbs appear well-formed but are positioned in a flexed posture. The image serves as a clear educational example of a cranial neural tube defect (NTD). It is highly relevant for medical studies in embryology, obstetrics, and pathology, specifically illustrating the morphological presentation of encephaloceles versus other cranial defects like anencephaly or exencephaly.

A clinical photograph of a fetus in posterior view, demonstrating a large occipital encephalocele. The primary pathology is a significant, sac-like protrusion in the occipital region of the head, indicated by a black arrow. This mass is smooth, taut, and spherical, representing the herniation of intracranial contents through a midline skull defect. The fetus exhibits thin, translucent skin with visible underlying vascular patterns, characteristic of early second-trimester development. The limbs appear well-formed but are positioned in a flexed posture. The image serves as a clear educational example of a cranial neural tube defect (NTD). It is highly relevant for medical studies in embryology, obstetrics, and pathology, specifically illustrating the morphological presentation of encephaloceles versus other cranial defects like anencephaly or exencephaly.

Reading File
Finding Sources
Loading Image
Loading Image
I now have all the material needed for a comprehensive seminar. Here is the full seminar on Neural Tube Defects:

Seminar: Neural Tube Defects (NTDs)

1. Introduction and Definition

Neural tube defects (NTDs) are midline congenital malformations involving some combination of neural tissue, meninges, and overlying bone or soft tissue. They collectively represent the most common CNS malformations in humans.
Two distinct pathogenic mechanisms underlie NTDs:
  1. Failure of neural tube closure - secondary mesenchymal tissue defects stem from aberrant skeletal modeling around the malformed tube (e.g., anencephaly, myelomeningocele)
  2. Primary bony defects - caused by abnormal axial mesoderm development leading to secondary CNS abnormalities (e.g., encephalocele, meningocele, spina bifida)
  • Robbins & Kumar Basic Pathology, p. 1044; Robbins Cotran & Kumar Pathologic Basis of Disease, p. 1150

2. Embryology - Neurulation

The embryonic neural tube is formed via neurulation, a process involving:
  • Shaping, folding, and midline fusion of the neural plate
  • Normally complete by day 25 after conception
NTDs result from failed caudal or cranial fusion of the neural tube, leaving neural tissue exposed. Neural tube closure at the cranial end is complete by approximately day 28 - before most pregnancies are even recognized, which is why periconceptional folate supplementation is the only effective preventive strategy.
  • Creasy & Resnik's Maternal-Fetal Medicine, p. 585

3. Epidemiology

ParameterData
Incidence (ONTD)~1:1000 live births
Most common formsAnencephaly and spina bifida
US annual burden~3,500 births per year
Most common locationLumbosacral region (>80% of cases)
Aneuploidy association10% (trisomy 18, trisomy 13, triploidy)
Recurrence risk3%-5% in subsequent pregnancies
Perinatal mortality (isolated ONTD)~10%-15%
  • Goldman-Cecil Medicine, p. 430; Creasy & Resnik's MFM, p. 585

4. Classification of NTDs

A. Spina Bifida (Most Common NTD)

A spectrum of posterior neural tube defects:
TypeDescription
Spina Bifida OccultaBony defect only; no exposed neural tissue; asymptomatic; no visible sac
MeningoceleSac containing only meninges and CSF; spinal cord not herniated
MyelomeningoceleSac containing spinal cord or other neural elements; most severe spinal form
MyeloschisisWide splaying of vertebral arch; no visible covering; neural tube completely exposed

B. Anencephaly

  • Malformation of the anterior end of the neural tube
  • Leads to absence of most of the brain and calvarium
  • Forebrain disrupted at approximately 28 days gestation
  • Remnant is the area cerebrovasculosa - disorganized brain tissue with admixed ependymia, choroid plexus, and meningothelial cells
  • Posterior fossa structures may be partially spared
  • Incompatible with sustained life

C. Encephalocele

  • Diverticulum of malformed CNS tissue extruding through a midline defect in the cranium
  • Most often occurs in the occipital region or posterior fossa
  • Anterior variants may involve orbit, ethmoid, or cribriform plate ("nasal glial heterotopia")
  • Robbins Cotran & Kumar Pathologic Basis of Disease, p. 1150-1151

5. Clinical Images

Prenatal ultrasound: types of NTD (A: anencephaly "Mickey Mouse sign", B: occipital encephalocele, C: thoracolumbar myelomeningocele)
Fetal ultrasound showing three types of NTDs: anencephaly, encephalocele, and myelomeningocele
Neonatal myelomeningocele: exposed lumbar neural placode in a prone neonate
Neonate with lumbosacral myelomeningocele showing exposed neural placode
Fetal surgery for myelomeningocele repair (in-utero closure)
Intraoperative view of fetal surgery for myelomeningocele repair

6. Etiology and Risk Factors

Risk FactorOdds Ratio (OR) / Risk
Folic acid deficiency (<400 mcg/day)OR = 3.72 (95% CI, 1.77-7.81)
Prior affected pregnancy3%-5% recurrence risk
Folate antagonists (valproic acid, carbamazepine)~1%-2% risk
Pregestational diabetes (type 1 or 2)OR = 2.88 (95% CI, 1.79-4.65)
Periconceptional fever (≥101°F)OR = 2.4 (95% CI, 1.5-4.0)
Maternal obesity (BMI ≥30)OR = 1.79 (95% CI, 1.51-2.13)
MTHFR mutation (677C>T)OR = 1.34 (95% CI, 1.17-1.54)
Other associations include VATER/VACTERL syndrome (vertebral defects, imperforate anus, tracheoesophageal fistula, renal defects).
  • Creasy & Resnik's MFM, p. 585

7. Genetics

NTDs illustrate multifactorial inheritance - both genetic and environmental factors are involved:
  • MTHFR gene polymorphism (677C>T) - impairs folate metabolism, raising NTD risk
  • Overall recurrence rate 4%-5% after one affected pregnancy
  • Differences in NTD rates among populations are partly explained by polymorphisms in enzymes involved in folic acid metabolism
  • Genomic sequencing has begun uncovering additional genetic variants
  • Emery's Elements of Medical Genetics and Genomics; Robbins Cotran & Kumar Pathologic Basis of Disease

8. Clinical Features of Myelomeningocele

Myelomeningocele occurs most commonly in the lumbosacral region and produces:
Neurological:
  • Motor and sensory deficits in the lower extremities (paraparesis/paraplegia)
  • Level of deficit corresponds to level of lesion
Urological and Bowel:
  • Neurogenic bladder and bowel
  • Urinary and fecal incontinence
Orthopedic:
  • Clubfeet (talipes)
  • Scoliosis and kyphoscoliosis
  • Hip dislocation
Cranial/CNS:
  • Arnold-Chiari malformation type II (downward herniation of brainstem and cerebellum)
  • Hydrocephalus (requires ventriculoperitoneal shunting)
  • Cerebral ventriculomegaly
  • Aberrant corpus callosum development (70%-90%)
  • Microcephaly (HC <5th percentile, 71%)
Infection risk: Thin overlying skin is prone to ulceration, leading to meningitis/myelitis
Prognosis depends on: level and size of lesion, associated anomalies, aneuploidy, degree of ventriculomegaly, and type of surgical closure. The larger and higher the lesion, the worse the prognosis for survival, motor function, and continence.
Long-term morbidity: paraplegia, developmental delay, learning disabilities, repeated VP shunt revisions.
  • Creasy & Resnik's MFM, p. 586-589; Robbins & Kumar Basic Pathology, p. 1051

9. Prenatal Diagnosis

Maternal Serum Screening

  • Elevated alpha-fetoprotein (AFP) in maternal serum - most ONTDs are associated with elevated MSAFP
  • AFP is also elevated in amniotic fluid; acetylcholinesterase in amniotic fluid is a more specific marker

First-Trimester Screening (11-14 weeks)

  • Intracranial translucency (IT): Qualitative non-visualization of the echolucent brainstem, 4th ventricle, or cisterna magna on mid-sagittal plane is suspicious for open spina bifida
  • Obliterated cisterna magna and elevated BS-BSOB ratio (brainstem-to-occipital bone ratio >1:1 is abnormal; >1:2 suspicious)
  • Early anatomy imaging at 15-16 weeks if first-trimester screen is abnormal

Second-Trimester Ultrasound Signs

SignFinding
Lemon signFrontal scalloping of the cranium (bifrontal retraction)
Banana signEffacement/obliteration of the cisterna magna due to Chiari II herniation
Spinal defectSagittal: dorsal defect with overlying cystic mass; Axial: V- or U-shaped posterior vertebrae

Amniocentesis

  • Karyotype / chromosomal microarray to assess for aneuploidy
  • Elevated amniotic fluid AFP + acetylcholinesterase confirms open NTD
  • Creasy & Resnik's MFM, p. 585-589; Tietz Textbook of Laboratory Medicine

10. Management

Antenatal Management

  1. Genetic counseling - discuss prognosis, recurrence risk, syndrome associations
  2. Amniocentesis with microarray or NIPT for karyotyping
  3. Fetal echocardiogram to assess cardiac structure
  4. Multidisciplinary counseling - involve pediatric neurosurgery, urology, orthopedics
  5. Fetal surgery (prenatal repair) - the landmark MOMS trial (Management of Myelomeningocele Study) showed prenatal repair significantly reduces need for VP shunting (40% vs. 82%) and improves motor outcomes vs. conventional postnatal surgery
    • Must be performed at highly specialized fetal surgery centers
    • Strict patient selection criteria apply
    • Delivery should be at a tertiary care center
  6. Delivery mode: Recent meta-analysis shows no difference in motor-anatomic level between vaginal vs. cesarean delivery; vaginal delivery less likely to need a shunt. Cesarean indicated for breech or severe hydrocephalus.
  7. Use nonlatex gloves throughout to prevent latex sensitization

Neonatal Management

  1. Protect open spinal lesion from infection and desiccation - wrap with moist sterile bandages in sterile isolette
  2. Use nonlatex gloves
  3. Immediate pediatric neurosurgery consultation
  4. Prophylactic antibiotics pending surgery
  5. Postnatal surgical repair within 48 hours of birth
  6. Followed by ongoing management of hydrocephalus, neurogenic bladder, orthopedic complications
  • Creasy & Resnik's MFM, p. 587-589

11. Prevention

Primary Prevention: Folic Acid

Folic acid supplementation before and during early pregnancy is the most evidence-based intervention:
PopulationFolic Acid DoseTiming
All women of childbearing age (low-risk)0.4 mg (400 mcg)/dayAt least 1 month before and through first trimester
High-risk women (prior NTD pregnancy)4 mg/dayStarting 1 month before conception
Key facts:
  • Folate supplements reduce NTD incidence by up to 70%
  • Supplemental folic acid before conception reduces recurrent ONTD risk by 70%
  • The US CDC, USPSTF, and AAP all recommend folic acid supplementation
  • Mandatory folic acid fortification of grain products in the US since 1998 has significantly reduced NTD prevalence
  • Average American folic acid intake is only ~half the recommended amount
Mechanism: Folate is essential for nucleotide synthesis and DNA methylation; deficiency impairs neural tube closure through uncertain mechanisms, possibly via effects on homocysteine metabolism and one-carbon transfer reactions.

Recent Evidence (2025-2026)

A 2025 systematic review (PMID: 40573151) found that maternal vitamin B12 status also plays an important independent role in NTD risk - low B12 is an emerging risk factor beyond folate deficiency alone, particularly relevant in populations without folic acid fortification.
A 2025 systematic review (PMID: 41640554) confirmed multiple influencing factors including maternal diabetes, obesity, anti-epileptic drugs, and nutritional deficiencies.
A 2024 meta-analysis (PMID: 39365302) documented the significant burden of NTDs in India, underscoring the need for fortification programs in low-income countries.
  • Neuroscience: Exploring the Brain 5th ed., p. 1963-1977; Creasy & Resnik's MFM, p. 406; Robbins Cotran & Kumar, p. 1151

12. Summary Table

FeatureDetails
Neural tube closureComplete by day 25-28 post-conception
Most common typeSpina bifida (spinal dysraphism)
Most common locationLumbosacral (>80%)
Key biochemical markerElevated AFP (maternal serum + amniotic fluid)
Best prenatal signLemon + banana sign on 2nd-trimester US
Genetic associationMTHFR 677C>T mutation
Key risk factorFolic acid deficiency
Prevention0.4 mg/day folic acid periconceptionally
High-risk prevention4 mg/day folic acid
Risk reduction with folateUp to 70%
Prenatal surgeryMOMS trial - proven benefit for myelomeningocele
Recurrence risk3%-5%

13. Key Teaching Points

  1. NTDs result from failure of neural tube closure, normally complete by day 25-28 post-conception
  2. The two main mechanisms are failed neural tube closure (anencephaly, myelomeningocele) and primary bony defects (spina bifida, encephalocele)
  3. Myelomeningocele is the most clinically significant survivable NTD; anencephaly is lethal
  4. The "lemon sign" + "banana sign" on second-trimester ultrasound are hallmark prenatal markers
  5. Elevated maternal serum AFP should always prompt careful sonographic evaluation of the spine
  6. Periconceptional folic acid (0.4 mg/day) reduces NTD risk by up to 70% - this is the single most important preventive measure
  7. High-risk women (prior affected pregnancy) should receive 4 mg/day starting one month before conception
  8. Prenatal surgical repair (MOMS trial) significantly improves outcomes compared to postnatal-only repair
  9. MTHFR gene polymorphisms and multifactorial inheritance are the genetic basis
  10. Emerging evidence highlights vitamin B12 as an additional important nutritional factor beyond folate
Sources: Creasy & Resnik's Maternal-Fetal Medicine (Principles and Practice); Robbins & Kumar Basic Pathology; Robbins, Cotran & Kumar Pathologic Basis of Disease; Goldman-Cecil Medicine; Emery's Elements of Medical Genetics and Genomics; Tietz Textbook of Laboratory Medicine, 7th Ed.; Neuroscience: Exploring the Brain, 5th Ed.; Katzung's Basic and Clinical Pharmacology, 16th Ed.

Summery conclusion bibloigraphy

Here is the Summary, Conclusion, and Bibliography section to complete your seminar on Neural Tube Defects:

Summary

Neural tube defects (NTDs) are among the most common and preventable congenital malformations, arising from failure of the embryonic neural tube to close completely by day 25-28 post-conception. The spectrum ranges from the lethal anencephaly (absence of brain and calvarium) to the survivable but highly morbid myelomeningocele (herniation of spinal cord and meninges through a vertebral defect), encephalocele (cranial herniation of brain tissue), and spina bifida occulta (asymptomatic bony defect only).
The lumbosacral region is affected in over 80% of cases. Myelomeningocele, the most clinically significant survivable form, causes a lifelong burden of lower limb paralysis, neurogenic bladder and bowel, hydrocephalus, Arnold-Chiari type II malformation, and orthopedic deformities including scoliosis and clubfeet.
Etiology is multifactorial. Folic acid deficiency is the most important modifiable risk factor, with an OR of 3.72. Other contributors include pregestational diabetes, maternal obesity, anti-epileptic drugs (valproic acid, carbamazepine), periconceptional fever, and the MTHFR 677C>T gene polymorphism. Recurrence risk following one affected pregnancy is 3%-5%.
Prenatal diagnosis relies on elevated maternal serum AFP as the primary biochemical screen, supported by second-trimester ultrasound findings - the classic lemon sign (frontal bossing/scalloping) and banana sign (obliterated cisterna magna from Chiari II herniation) - and confirmatory amniocentesis for AFP, acetylcholinesterase, and karyotype.
Management has been transformed by the MOMS trial, which demonstrated that prenatal in-utero surgical repair of myelomeningocele significantly reduces the need for ventriculoperitoneal shunting (40% vs. 82%) and improves motor outcomes compared to postnatal repair alone. Neonatal management requires surgical closure within 48 hours, use of nonlatex precautions, and lifelong multidisciplinary follow-up.
Prevention is the cornerstone of NTD control. Periconceptional folic acid supplementation (0.4 mg/day for all women of childbearing age; 4 mg/day for high-risk women) reduces NTD occurrence and recurrence by up to 70%. Population-level folic acid fortification of grain products (introduced in the USA in 1998) has resulted in a significant decline in NTD prevalence. Emerging evidence (2025) also implicates maternal vitamin B12 deficiency as an independent additional risk factor beyond folate alone.

Conclusion

Neural tube defects remain a major cause of infant mortality and lifelong neurodevelopmental disability worldwide, yet they are substantially preventable. The critical window for prevention - neural tube closure at day 25-28 of embryogenesis - occurs before most women even realize they are pregnant, making periconceptional folic acid supplementation and food fortification programs the most powerful tools available.
Advances in prenatal diagnosis have enabled early detection and counseling. The paradigm shift toward fetal surgery for myelomeningocele, validated by the landmark MOMS trial, has significantly improved neurological outcomes. Multidisciplinary care from neurosurgery, urology, orthopedics, and developmental pediatrics remains essential for optimizing quality of life in affected individuals.
Public health education to ensure that all women of reproductive age consume adequate folic acid - whether through diet, supplementation, or food fortification - is the single most impactful strategy to reduce the global NTD burden. As newer research highlights the role of vitamin B12 and genetic polymorphisms (MTHFR), future prevention strategies may need to extend beyond folate supplementation alone.

Bibliography

  1. Creasy RK, Resnik R, et al. Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice. 8th ed. Philadelphia: Elsevier; 2023. Chapter 26: Neural Tube Defects, pp. 584-589.
  2. Kumar V, Abbas AK, Aster JC. Robbins and Cotran Pathologic Basis of Disease. 10th ed. Philadelphia: Elsevier; 2021. Chapter 28: Neural Tube Defects, pp. 1150-1151.
  3. Kumar V, Abbas AK, Aster JC. Robbins and Kumar's Basic Pathology. 11th ed. Philadelphia: Elsevier; 2023. Chapter 21: Neural Tube Defects, pp. 1044-1052.
  4. Goldman L, Cooney KA. Goldman-Cecil Medicine. 27th ed. Philadelphia: Elsevier; 2024. Neural Tube Defects, pp. 430-432.
  5. Turnpenny PD, Ellard S, Cleaver R. Emery's Elements of Medical Genetics and Genomics. 16th ed. Philadelphia: Elsevier; 2022. Multifactorial Inheritance - Neural Tube Defects, pp. 4327-4331.
  6. Bear MF, Connors BW, Paradiso MA. Neuroscience: Exploring the Brain. 5th ed. Burlington: Jones & Bartlett Learning; 2020. Nutrition and the Neural Tube, pp. 1963-1977.
  7. Katzung BG. Basic and Clinical Pharmacology. 16th ed. New York: McGraw-Hill; 2023. Folic Acid - Prevention of Neural Tube Defects, p. 956.
  8. Rifai N, Chiu RWK, Young I, et al. Tietz Textbook of Laboratory Medicine. 7th ed. Philadelphia: Elsevier; 2023. Maternal Serum AFP Screening and Neural Tube Defects.
  9. Park K. Park's Textbook of Preventive and Social Medicine. 26th ed. Jabalpur: Banarsidas Bhanot; 2023. Defects at Birth: Neural Tube Defects, p. 2732.
  10. Adzick NS, Thom EA, Spong CY, et al. (MOMS Investigators). A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011;364(11):993-1004. PMID: 21306277.
  11. Sinha A, P P, Chakraborty H. Burden of neural tube defects in India: a systematic review and meta-analysis. Childs Nerv Syst. 2024 Dec. PMID: 39365302
  12. Nie L, Liu X, Li X. Beyond Folate: The Emerging Role of Maternal Vitamin B12 in Neural Tube Development. Nutrients. 2025 Jun 19. PMID: 40573151
  13. Wu X, Bian X, Zheng Q. Influencing factors of neural tube malformation: a systematic review and meta-analysis. Afr Health Sci. 2025 Mar. PMID: 41640554
  14. Centers for Disease Control and Prevention (CDC). Use of folic acid for the prevention of spina bifida and other neural tube defects. MMWR. 1991;40(30):513-516.
  15. US Preventive Services Task Force. Folic acid supplementation for the prevention of neural tube defects: USPSTF recommendation statement. JAMA. 2017;317(2):183-189.
This is a shared conversation. Sign in to Orris to start your own chat.